John R. Swiston

Vancouver Island Program
Victoria, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Effect of Community Size and Commute Time on Severity of Pulmonary Arterial Hypertension at Diagnosis and Follow-up in Patients Across 3 Sites.

Effect of Community Size and Commute Time on Severity of Pulmonary Arterial Hypertension at Diagnosis and Follow-up in Patients Across 3 Sites.

Journal: CJC open

Published: February 21, 2026

Outcomes of transition from selexipag to parenteral prostacyclin analogues in patients with pulmonary arterial hypertension.

Outcomes of transition from selexipag to parenteral prostacyclin analogues in patients with pulmonary arterial hypertension.

Journal: ERJ open research

Published: December 03, 2025

Real-world Persistence on Selexipag for Pulmonary Arterial Hypertension in Canada.

Real-world Persistence on Selexipag for Pulmonary Arterial Hypertension in Canada.

Journal: CJC open

Published: September 18, 2025

Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort Study.

Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort Study.

Journal: Pulmonary circulation

Published: August 24, 2025

Study of angiogenic cell therapy for progressive pulmonary arterial hypertension: intervention with repeat dosing of eNOS-enhanced EPCs: the SAPPHIRE trial.

Study of angiogenic cell therapy for progressive pulmonary arterial hypertension: intervention with repeat dosing of eNOS-enhanced EPCs: the SAPPHIRE trial.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: February 06, 2025

Association Between the Pulmonary Artery Pulsatility Index and Prognosis in Pulmonary Arterial Hypertension: A Multicentre Study.

Association Between the Pulmonary Artery Pulsatility Index and Prognosis in Pulmonary Arterial Hypertension: A Multicentre Study.

Journal: CJC open

Published: January 06, 2023

Priorities for pulmonary hypertension research: A James Lind Alliance priority setting partnership.

Priorities for pulmonary hypertension research: A James Lind Alliance priority setting partnership.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: May 26, 2022

Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial.

Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: September 20, 2021

Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC/ERS guideline era.

Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC/ERS guideline era.

Journal: The European respiratory journal

Published: June 02, 2021

Evolving Paradigms in the Treatment of Atrial Septal Defects With Pulmonary Arterial Hypertension.

Evolving Paradigms in the Treatment of Atrial Septal Defects With Pulmonary Arterial Hypertension.

Journal: Cardiology in review

Published: September 21, 2020

Impact of targeted pulmonary arterial hypertension therapy in patients with combined post- and precapillary pulmonary hypertension.

Impact of targeted pulmonary arterial hypertension therapy in patients with combined post- and precapillary pulmonary hypertension.

Journal: American heart journal

Published: August 13, 2020

Does community size or commute time affect severity of illness at diagnosis or quality of care in a centralized care model of pulmonary hypertension?

Does community size or commute time affect severity of illness at diagnosis or quality of care in a centralized care model of pulmonary hypertension?

Journal: International journal of cardiology

Published: July 02, 2020

Showing 1-12 of 33

Last Updated: 09/26/2026